Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Aclaris Therapeutics will webcast its CEO’s September 10, 2026 Cantor conference fireside chat for investors and other stakeholders.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Aclaris Therapeutics (ACRS) will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference in New York on September 10, 2026, at 2:45 PM ET.
The session will feature Chief Executive Officer Dr. Neal Walker. A live and archived webcast will be available on the Events page of the Aclaris website for at least 30 days.
Details
Market move: ACRS -3.72% in the Sep 3 session. 2026 Cantor conference
On Sep 3, the day this news came out, ACRS closed 3.72% below the previous close. Argus tracked a trough of -3.1% from its starting point during tracking. Our momentum scanner recorded 8 alerts for this stock that day.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Event date
- September 10, 2026
- 2026 Cantor Global Healthcare Conference
- Fireside chat time
- 2:45 PM ET
- September 10, 2026
- Webcast availability
- at least 30 days
- Aclaris website webcast archive
Historical Context
-
FDA granted Fast Track status for modzatinib in moderate to severe lichen planus
-
Quarterly results included a $21.5 million net loss and $1.6 million revenue
-
Company scheduled a June 4 fireside chat at the Jefferies healthcare conference
-
President and COO was scheduled to present at the Bank of America healthcare conference
-
Positive Phase 1a data and cash resources supporting operations through end of 2028
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WAYNE, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that on Thursday, September 10, 2026, at 2:45 PM ET, Aclaris’ Chief Executive Officer Dr. Neal Walker will participate in a fireside chat during the 2026 Cantor Global Healthcare Conference in New York, NY.
A live and archived webcast of this event will be accessible on the Events page of the Aclaris website, www.aclaristx.com. The webcast will be available on the Aclaris website for at least 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on LinkedIn.
Aclaris Therapeutics Contact:
Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Aclaris Therapeutics (ACRS) present at the 2026 Cantor Global Healthcare Conference?
Aclaris Therapeutics is scheduled to participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Thursday, September 10, 2026, at 2:45 PM ET in New York, NY.
How can investors access the Aclaris Therapeutics (ACRS) webcast for the 2026 Cantor conference?
A live and archived webcast of the Aclaris fireside chat will be accessible on the Events page of the company’s website, www.aclaristx.com. The archived webcast will remain available on the site for at least 30 days.
Who will represent Aclaris Therapeutics (ACRS) at the 2026 Cantor Global Healthcare Conference?
Aclaris Therapeutics will be represented by its Chief Executive Officer, Dr. Neal Walker, who will participate in a fireside chat during the conference.